Top

Cellular Oncology

Published in:

01-02-2018 | Original Paper

Memory CD4⁺ T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells

Authors: Yasmin Vahidi, Zahra Faghih, Abdol-Rasoul Talei, Mehrnoosh Doroudchi, Abbas Ghaderi

Published in: Cellular Oncology | Issue 1/2018

Abstract

Background

The compartments of memory T cells play a fundamental role in the immune system by substantiating specific and acquired immunity. A new subset of memory cells, T stem cell memory (T_SCM) cells, with stem cell-like properties, a high capacity to proliferate, a long survival, and an ability to differentiate into all effector and memory cells has recently been introduced. In the present study, we aimed to determine the frequency of CD4⁺ T_SCM and other T memory cell subsets in tumor draining lymph nodes of breast cancer patients.

Materials and methods

Mononuclear cells were obtained from axillary lymph nodes of 52 untreated patients with breast cancer (BC) and stained with fluorochrome conjugated anti-CD4, −CCR7, −CD45RO and -CD95 antibodies to detect different subtypes of memory cells in CD4⁺ lymphocyte populations. Data were acquired using a four-color FACSCalibur flow cytometer and analyzed using CellQuest Pro software.

Results

We found that >70% of CD4⁺ lymphocytes in draining lymph nodes of BC patients exhibited a memory phenotype of which 7.04 ± 1.04% had a T_SCM phenotype (CD4⁺CCR7⁺CD45RO⁻CD95⁺). The frequency of T_SCM cells was significantly higher in tumor positive lymph nodes compared to tumor negative lymph nodes (p = 0.026) as well as among those patients who had at least one affected lymph node (p = 0.012). Moreover, we found that the total frequency of central memory T cells (T_CM) with a low expression of CD45RO was significantly higher among these patients. The percentage of CD45RO^Low T_CM cells was also found to increase with tumor progression from stage I to stage III (p = 0.020). On the other hand, we found that the percentage of CD95^Hi effector memory T cells (T_EM) was significantly decreased in involved lymph nodes (p = 0.009).

Conclusion

Our data suggest that following long-term exposure to putative tumor antigens, T_SCM cells proliferate to generate a pool of committed memory and effector T cells. As the tumor progresses, the immunosuppressive milieu induced by tumor cells may slow down the differentiation of CD45RO^Low T_CM cells to more functional sub-populations.

Available only for authorised users

K. Tokoyoda, A.E. Hauser, T. Nakayama, A. Radbruch, Organization of immunological memory by bone marrow stroma. Nat Rev Immunol 10, 193–200 (2010). https://doi.org/10.1038/nri2727 CrossRefPubMed

N.S. Butler, J.T. Harty, The role of inflammation in the generation and maintenance of memory T cells. Adv Exp Med Biol 684, 42–56 (2010)CrossRefPubMed

M.K. MacLeod, J.W. Kappler, P. Marrack, Memory CD4 T cells: Generation, reactivation and re-assignment. Immunology 130, 10–15 (2010). https://doi.org/10.1111/j.1365-2567.2010.03260.x CrossRefPubMedPubMedCentral

N.P. Weng, Y. Araki, K. Subedi, The molecular basis of the memory T cell response: Differential gene expression and its epigenetic regulation. Nat Rev Immunol 12, 306–315 (2012). https://doi.org/10.1038/nri3173 CrossRefPubMedPubMedCentral

T. Sathaliyawala, M. Kubota, N. Yudanin, D. Turner, P. Camp, J.J. Thome, K.L. Bickham, H. Lerner, M. Goldstein, M. Sykes, T. Kato, D.L. Farber, Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 38, 187–197 (2013). https://doi.org/10.1016/j.immuni.2012.09.020 CrossRefPubMed

M. Takeshita, K. Suzuki, Y. Kassai, M. Takiguchi, Y. Nakayama, Y. Otomo, R. Morita, T. Miyazaki, A. Yoshimura, T. Takeuchi, Polarization diversity of human CD4+ stem cell memory T cells. Clin Immunol 159, 107–117 (2015). https://doi.org/10.1016/j.clim.2015.04.010 CrossRefPubMed

F. Sallusto, A. Langenkamp, J. Geginat, A. Lanzavecchia, Functional subsets of memory T cells identified by CCR7 expression. Curr Top Microbiol Immunol 251, 167–171 (2000). https://doi.org/10.1007/978-3-642-57276-0_21 PubMed

S.C. Jameson, D. Masopust, Diversity in T cell memory: An embarrassment of riches. Immunity 31, 859–871 (2009). https://doi.org/10.1016/j.immuni.2009.11.007 CrossRefPubMedPubMedCentral

L. Gattinoni, E. Lugli, Y. Ji, Z. Pos, C.M. Paulos, M.F. Quigley, J.R. Almeida, E. Gostick, Z. Yu, C. Carpenito, E. Wang, D.C. Douek, D.A. Price, C.H. June, F.M. Marincola, M. Roederer, N.P. Restifo, A human memory T cell subset with stem cell-like properties. Nat Med 17, 1290–1297 (2011). https://doi.org/10.1038/nm.2446 CrossRefPubMedPubMedCentral

10.

J.K. Flynn, P.R. Gorry, Stem memory T cells (TSCM)-their role in cancer and HIV immunotherapies. Clin Transl Immunol 3 (2014). https://doi.org/10.1038/cti.2014.16

11.

L. Gattinoni, Memory T cells officially join the stem cell club. Immunity 41, 7–9 (2014). https://doi.org/10.1016/j.immuni.2014.07.003 CrossRefPubMed

12.

C.J. Luckey, C.T. Weaver, Stem-cell-like qualities of immune memory; CD4+ T cells join the party. Cell Stem Cell 10, 107–108 (2012). https://doi.org/10.1016/j.stem.2012.01.011 CrossRefPubMedPubMedCentral

13.

Y.D. Mahnke, T.M. Brodie, F. Sallusto, M. Roederer, E. Lugli, The who's who of T-cell differentiation: Human memory T-cell subsets. Eur J Immunol 43, 2797–2809 (2013). https://doi.org/10.1002/eji.201343751 CrossRefPubMed

14.

S.M. Kaech, Celebrating diversity in memory T cells. J Immunol 192, 837–839 (2014). https://doi.org/10.4049/jimmunol.1303268 CrossRefPubMedPubMedCentral

15.

L. Gattinoni, X.S. Zhong, D.C. Palmer, Y. Ji, C.S. Hinrichs, Z. Yu, C. Wrzesinski, A. Boni, L. Cassard, L.M. Garvin, C.M. Paulos, P. Muranski, N.P. Restifo, Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med 15, 808–813 (2009). https://doi.org/10.1038/nm.1982 CrossRefPubMedPubMedCentral

16.

A. Scherpereel, B.D. Grigoriu, M. Noppen, T. Gey, B. Chahine, S. Baldacci, J. Trauet, M.C. Copin, J.P. Dessaint, H. Porte, M. Labalette, Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid. BMC Cancer 13, 1471–2407 (2013). https://doi.org/10.1186/1471-2407-13-324 CrossRef

17.

Y. Nagai, M. Kawahara, M. Hishizawa, Y. Shimazu, N. Sugino, S. Fujii, N. Kadowaki, A. Takaori-Kondo, T memory stem cells are the hierarchical apex of adult T-cell leukemia. Blood 125, 3527–3535 (2015). https://doi.org/10.1182/blood-2014-10-607465 CrossRefPubMed

18.

K. Hotta, M. Sho, K. Fujimoto, K. Shimada, I. Yamato, S. Anai, N. Konishi, Y. Hirao, K. Nonomura, Y. Nakajima, Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma. Br J Cancer 105, 1191–1196 (2011). https://doi.org/10.1038/bjc.2011.368 CrossRefPubMedPubMedCentral

19.

A. Oberg, S. Samii, R. Stenling, G. Lindmark, Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors. Int J Color Dis 17, 25–29 (2002). https://doi.org/10.1007/s003840100337 CrossRef

20.

K. Enomoto, M. Sho, K. Wakatsuki, T. Takayama, S. Matsumoto, S. Nakamura, T. Akahori, T. Tanaka, K. Migita, M. Ito, Y. Nakajima, Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma. Clin Exp Immunol 168, 186–191 (2012). https://doi.org/10.1111/j.1365-2249.2012.04565.x CrossRefPubMedPubMedCentral

21.

R. Yajima, T. Yajima, T. Fujii, Y. Yanagita, T. Fujisawa, T. Miyamoto, S. Tsutsumi, M. Iijima, H. Kuwano, Tumor-infiltrating CD45RO(+) memory cells are associated with a favorable prognosis breast cancer. Breast Cancer 23, 668–674 (2016). https://doi.org/10.1007/s12282-015-0622-y CrossRefPubMed

22.

M. Pincha, P. Boonsawat, C. Domschke, P. Beckhove, Characterizing tumor-specific memory stem like T cells in blood and bone marrow of breast cancer patients. Cancer Res 74, 4076 (2014). https://doi.org/10.1158/1538-7445.AM2014-4076 CrossRef

23.

V. Schirrmacher, M. Feuerer, P. Beckhove, T. Ahlert, V. Umansky, T cell memory, anergy and immunotherapy in breast cancer. J Mammary Gland Biol Neoplasia 7, 201–208 (2002). https://doi.org/10.1023/A:1020308104613 CrossRefPubMed

24.

M. Feuerer, M. Rocha, L. Bai, V. Umansky, E.F. Solomayer, G. Bastert, I.J. Diel, V. Schirrmacher, Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients. Int J Cancer 92, 96–105 (2001). https://doi.org/10.1002/1097-0215(200102)9999:9999<::AID-IJC1152>3.0.CO;2-Q CrossRefPubMed

25.

P. Correale, P. Tagliaferri, A. Fioravanti, M.T. Del Vecchio, C. Remondo, F. Montagnani, M.S. Rotundo, C. Ginanneschi, I. Martellucci, E. Francini, M.G. Cusi, P. Tassone, G. Francini, Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 trial). Clin Cancer Res 14, 4192–4199 (2008). https://doi.org/10.1158/1078-0432.ccr-07-5278 CrossRefPubMed

26.

F. Pages, A. Berger, M. Camus, F. Sanchez-Cabo, A. Costes, R. Molidor, B. Mlecnik, A. Kirilovsky, M. Nilsson, D. Damotte, T. Meatchi, P. Bruneval, P.H. Cugnenc, Z. Trajanoski, W.H. Fridman, J. Galon, Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353, 2654–2666 (2005). https://doi.org/10.1056/NEJMoa051424 CrossRefPubMed

27.

M.T. Hueman, A. Stojadinovic, C.E. Storrer, Z.A. Dehqanzada, J.M. Gurney, C.D. Shriver, S. Ponniah, G.E. Peoples, Analysis of naive and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine. Cancer Immunol Immunother 56, 135–146 (2007). https://doi.org/10.1007/s00262-006-0188-9 CrossRefPubMed

28.

Y. Xie, B.-W. Luo, X.-D. Yuan, P.-K. Tian, X. Ou, Z.-W. Lin, X.-P. Liu, J.-K. Liu, Expression characteristics of surface markers of memory T cells, CD45RO, CCR7 and CD62L, in tumor-infiltrating lymphocytes in liver cancer tissues of patients with hepatocellular carcinomas. J Clin Cell Immunol 4, 181 (2013). https://doi.org/10.4172/2155-9899.1000181

29.

Z. Faghih, N. Erfani, M.R. Haghshenas, A. Safaei, A.R. Talei, A. Ghaderi, Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes. Immunol Lett 158, 57–65 (2014). https://doi.org/10.1016/j.imlet.2013.11.021 CrossRefPubMed

Title: Memory CD4+ T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells
Authors: Yasmin Vahidi
Zahra Faghih
Abdol-Rasoul Talei
Mehrnoosh Doroudchi
Abbas Ghaderi
Publication date: 01-02-2018
Publisher: Springer Netherlands
Published in: Cellular Oncology / Issue 1/2018
Print ISSN: 2211-3428
Electronic ISSN: 2211-3436
DOI: https://doi.org/10.1007/s13402-017-0352-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2018

Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report

Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma

A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report

Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells

Metabolic iodine and tumours

A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation

Keynote webinar | Spotlight on antibody–drug conjugates in cancer